21st June 2024

A patient undergoing therapy for MDR-TB has raised concerns regarding new-onset

A patient undergoing therapy for MDR-TB has raised concerns regarding new-onset, progressive discolouration of their skin. On examination, brown-red discolouration of the skin is evident, most evident on her face. She is understandably upset about the effect this has had on her appearance. Which of the following agents used in MDR-TB is most likely responsible for this complication?

Select the SINGLE most appropriate option from the list below. Select ONE option only.